{"id":"W2119754700","doi":"10.1016/s0140-6736(07)60033-6","title":"Drug treatments for obesity: orlistat, sibutramine, and rimonabant","year":2007,"lang":"en","type":"review","venue":"The Lancet","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":750,"is_retracted":false,"has_abstract":false,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta Hospital","funders":"","keywords":"Orlistat; Sibutramine; Medicine; Weight loss; Rimonabant; Internal medicine; Obesity; Adverse effect; Pharmacology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1202510159726433,"score_gpt":0.4276631972802757,"score_spread":0.3074121813076324,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}